Literature DB >> 16980293

Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.

Harald Seifert, Danuta Stefanik, Hilmar Wisplinghoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16980293     DOI： 10.1093/jac/dkl383

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  14 in total

1.  Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a nigerian tertiary hospital ICU.

Authors:  Victor Ugochukwu Nwadike; Chiedozie Kingsley Ojide; Eziyi Iche Kalu
Journal:  Afr J Infect Dis       Date:  2014

2.  Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline.

Authors:  Tekin Tas; Esra Kocoglu; Zafer Mengeloglu; Ozlem Bucak; Seyda Karabörk
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

3.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

Review 4.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

5.  Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California.

Authors:  Sonya C Valentine; Deisy Contreras; Stephanie Tan; Lilian J Real; Sheena Chu; H Howard Xu
Journal:  J Clin Microbiol       Date:  2008-06-04       Impact factor: 5.948

Review 6.  Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Authors:  Drosos E Karageorgopoulos; Theodore Kelesidis; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-04-24       Impact factor: 5.790

Review 7.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Detection of KPC in Acinetobacter spp. in Puerto Rico.

Authors:  Iraida E Robledo; Edna E Aquino; María I Santé; Jorge L Santana; Diana M Otero; Carlos F León; Guillermo J Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

9.  Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China.

Authors:  Nian-Zhi Ning; Xiong Liu; Chun-Mei Bao; Su-Ming Chen; En-Bo Cui; Ju-Ling Zhang; Jie Huang; Fang-Hong Chen; Tao Li; Fen Qu; Hui Wang
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

10.  Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals.

Authors:  Mohammad Hossein Maleki; Zamberi Sekawi; Setareh Soroush; Farid Azizi-Jalilian; Khairollah Asadollahi; Sattar Mohammadi; Mohammad Emaneini; Morovat Taherikalani
Journal:  Iran J Basic Med Sci       Date:  2014-01       Impact factor: 2.699
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.